Ami Organics Ltd - AMI ORGANICS Share Price

Sector: Pharmaceuticals | ISIN: INE00FF01017
₹ 1,120.00 (1.22%) icon19 Mar, 2024, 3:19:57 PM

Ami Organics Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/19/2024 3:19:57 PM

    ₹ 1120 13.50 1.22
  • Open
  • ₹ 1,110
  • Prev. Close
  • ₹ 1,106.5
  • Turnover(Lac.)
  • ₹ 1,810
  • Day's High
  • ₹ 1,148.05
  • Day's Low
  • ₹ 1,097.2
  • 52 Week's High
  • ₹ 1,388.95
  • 52 Week's Low
  • ₹ 861
  • Book Value
  • ₹ 176.31
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 4,130.62
  • P/E
  • 62.24
  • EPS
  • 17.79
  • Divi. Yield
  • 0.27

Ami Organics Ltd Corporate Actions

05 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Feb , 2024

12:00 AM

02 Nov , 2023

12:00 AM

02 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Aug , 2023

12:00 AM

AGM

Announcement date: 25 Aug , 2023

View Details

13 May , 2023

12:00 AM

Dividend

Dividend amount: 3
Announcement date: 13 May , 2023

View Details

25 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2023

12:00 AM

01 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Sep , 2023

12:00 AM

BookCloser

View Details

Ami Organics Ltd News and Update

Image not found
  • 05 March, 2024 |
  • 12:23 AM

Centrum Capital Ltd., Emkay Global Financial Services Ltd., and Keynote Financial Services Ltd. are serving as the book-running lead managers

Image not found
Article Image

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Ami Organics Ltd SHAREHOLDING SNAPSHOT
19 March , 2024 | 03:40 PM

PROMOTER - TOTAL39.91%

Indian: 39.91%

Foreign: 0%

NON-PROMOTER - TOTAL 60.09%

Institutions: 19.23%

Non-Institutions: 40.86%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Ami Organics Ltd FINANCIALS

Ami Organics Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Ami Organics Ltd

  • Nareshbhai Ramjibhai Patel
  • Chairman / Executive Director
  • Chetankumar Chhaganlal Vaghasia
  • Whole-time Director
  • Virendra Nath Mishra
  • Whole-time Director
  • Ram Mohan Rao Locande
  • Whole-time Director
  • Girikrishna Maniar
  • Independent Non Exe. Director
  • Hetal Gandhi
  • Independent Non Exe. Director
  • Richa M. Goyal
  • Independent Non Exe. Director
  • Anita Bandyopadhyay
  • Independent Non Exe. Director

Summary

The Company was initially formed as a partnership firm in the name of Ami Organics with effect from 03 January 2004 at Surat, India. The firm converted into a private limited company under the Companies Act, 1956 under the name of Ami Organics Private Limited with a certificate of incorporation dated 12 June 2007. Subsequently, the Company was converted into a public limited company, following which the Companys name was changed to Ami Organics Limited, and a fresh certificate of incorporation was issued by RoC on 18 April 2018. The company is one of the leading research and development (R&D) driven manufacturers of specialty chemicals with varied end usage, focussed towards the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from the recent acquisition of the business of Gujarat Organics Limited (GOL). As per the F&S Report, the company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which the company manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, antiinflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and... Read More


Reports by Ami Organics Ltd


Reports by Ami Organics Ltd

Company FAQ

No Record Found